Advanced Biomed Inc.
Advanced Biomed Inc.
Advanced Biomed Inc.
ADVB
ADVB
Nasdaq
Health Technology
Biotechnology
12.62
USD
+5.5379
+78.22%
Buka: 07-22 18:54 (UTC+0)

ADVB Statistik Utama

Tinggi
18.73
Buka
8.32
Volume
23.55M
Rendah
8.08
Cierre anterior
7.08
Nilai Perdagangan
312.10M
Tertinggi 52M
18.73
Volume relatif
5.795
Amplitudo (%)
150.42%
Terendah 52M
3.61
Tingkat Perputaran
1425.97%
Kap Pasar
11.69M
P/E (TTM)
44.47
P/E (Tahunan)
--
P/B
1.27
P/S
--
Laba per Saham (EPS)
0.159
Dividen (TTM)
0
Imbal Hasil Dividen
0.00%
Saham beredar
1.65M
Mata uang
USD

ADVB Kinerja Harga

7 hari
30 hari
90 hari
180 hari
Sejak awal tahun
1 Tahun
ADVB Distribusi Arus Dana
ADVB Volume Short Sale Harian
ADVB Riwayat Short Interest
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.6179. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47. On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 56.16% above the daily low and 32.63% below the daily high, placing ADVB di sekitar bagian tengah de its most recent trading range. Trading volume currently stands at 23.55M, compared with an average daily volume of 4.06M. This suggests that trading activity is jauh di atas level biasanya than usual. Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 249.53% above its 52-week low and 32.63% below its 52-week high.
Nama Perusahaan
Advanced Biomed Inc.
Sektor
Health Technology
Industri
Biotechnology
Bursa
Nasdaq
Jumlah Karyawan
31
Ukuran Lot
100
Mata uang
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

ADVB FAQ

Cari
Lebih